Lyme is all around us but I believe we will help many more if we give up on blaming everything on the tick related introduction of more pathogens than we had the day before we are bit.  It is confusing to people, as too often Lyme tests are inconclusive. So let’s rename the condition LIMES (Lowered Immune Metabolic Encephalopathy Syndrome) or LIMNS (for Neuropathy, as in MS like conditions) or LIMAS (Arthropathy when it is more arthritic in presentation), as these names move us closer to seeing the true picture.

It is sad to turn patients away with these devastating symptoms when the Infectious Disease Association guidelines force us to say it is Lyme. I am certain broadening the approach to Food sensitivities, other Infections, Genetics, Heavy metals and Hormones and Toxins would wind up with better results than the low batting average that is reported from long-term IV antibiotics, which are often reported as low as 33% about which Lyme critics point out is the response rate to placebos. If we focus on my F.I.G.H.T. program and do something to help deal with the obvious issues that can be found in almost anyone in any of these categories, we can be more cost effective and actually help more patients, as they will stop looking just for a doctor that will interpret their test as positive for Lyme.

Realize that everyone today will fail the Mount Sinai School of Medicine $4900 test for toxins. So let’s blame the neurotoxins and endocrine disruptors just like we blame the total body burden of infection, as properly tested everyone will have some Chlamydia or CMV or Coxackie or Candida and so on.

No one will pass the test at Harvard for bone lead levels. They have shown that the level in bone is in equilibrium with most other tissues in the body including the eye so there is a direct correlation with how high lead in bones is and how soon you develop a cataract. So there is no one on earth that does not need some lead out and since Lead makes Mercury as much as 100 times more toxic, who needs tons of tests to know what to do in most of the categories my F.I.G.H.T. program acronym represents.

So would it not be better medicine to offer some oral detoxification for the Heavy metals and the Toxins, with ZeoGold and BIOE’NR-G’Y C, Beyond Fiber, and some organic Greens and some Maca and help people eliminate suspect foods for a time. Before letting the outcome of the patient’s intervention with the doctor pass on the results of unreliable negative lab tests for Lyme, because of immune suppression until some treatment is started for awhile and then the test for Lyme often changes to positive. What a waste to not simply realize we are confronted with an epidemic of autoimmune diseases that has so many different presentations that over 100 conditions are now considered to be autoimmune related. These conditions deserve meaningful intervention and my F.I.G.H.T. program protects patients from Johnny One Note health care providers who focus only on one aspect of my program and thus only help a small percentage of patients.

Let’s broaden our approach and help everyone with empowering knowledge. Everyone we see today needs help to optimize every one of the categories in F.I.G.H.T. If we expand the FIGHT concept we would make F stand for FOCUS on positive thinking not just Food and H for hormones and Heavy metals and then really the G is not just Genetics but also the entire new field of Epigenetics where exposures to BISPHENOL A have led to overnight changes in Gene activation. They are permanent until treated with aggressive methylation support, as with the MSM and TMG found in BIOE’NR-G’Y C and the active forms of Folic Acid found in Beyond B12.

We all remember AIDS is acquired immune deficiency so now I recommend that this new epidemic just be renamed LOWERED IMMUNE METABOLIC ENCEPHALOPATHY SYNDROME or LIMES then we can start to be much more cost effective in improving the health of many who suffer without excess reliance on some lab test for Lyme related infections.

This link to MEDSCAPE may help broaden your knowledge regarding some aspects of this new epidemic. By putting LIMES category into a new AUTOIMMUNE RELATED condition it forces us to broaden our approach beyond antibiotics can help our patients who still will not be covered by insurance but at least they will not be turned away without receiving real help and we will not waste time with medical board fights. Patients will be taught something that I am confident for most will help them improve their health more than getting 6 months of IV antibiotics even if it were fully covered by their insurance company. It is not just an antibiotic deficiency we are encountering; read the book BEYOND ANTIBIOTICS!

It is like the old adage TEACH a man to fish or give him a fish; I prefer the teaching approach. Knowledge of what is really wrong with our health can be empowering but to put everything on one infection or one toxin and ignore leaky gut and food sensitivities, etc I feel  means we provide little long-term meaningful help to patients who deserve a broader understanding of what is really going wrong with their health.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

A Case of Ascending Paralysis: the Signs and Symptoms of Tick Paralysis
Menyoli Malafa, MSII; Veronica Tucci, JD, MS IV; Albert Vincent, PhD; Sajeel Chowdhary, MD
Posted: 03/26/2009; American Academy of Emergency Medicine.
2009;16(1):22, 26, 27 © 2009 American Academy of Emergency Medicine
http://www.medscape.com/viewarticle/589591

Summary
Tick paralysis (TP), a response to the neurotoxic effects of the salivary secretions produced by attached hard ticks (Ixodidae), is a syndrome that mimics a large number of better known neurological disorders. TP is a sporadic, seasonal, rural disorder in which acute ataxia often develops five to six days following a history of walking in grass or low brush, followed by ascending flaccid paralysis. Recognition and timely removal of the tick usually leads to complete resolution of symptoms, whereas continued feeding can lead to respiratory arrest and death. Follow-up includes species determination and patient surveillance for tick-borne infectious disease.

Discussion
TP is a worldwide disease, occurring in Australia, Europe, South Africa and throughout North America. In the United States, most cases occur in the Rocky Mountain states and the Pacific Northwest, including Washington, Montana, Oregon, Idaho, Wyoming, Nevada, Utah, Colorado and the northern parts of Arizona, New Mexico and California. However, cases have also been reported in central, southern and eastern states, including Texas, Oklahoma, Mississippi, Florida, Georgia, North Carolina, South Carolina, Virginia, Washington, D.C., Pennsylvania and New York. In Canada, most cases are encountered in the western part of the country, primarily southern British Columbia.[1,2] More than 60 species of ticks are known to cause paralysis, but only a handful are responsible for most cases. In North America, the disease is associated primarily with six species: Dermacentor andersoni (‘Rocky Mountain wood tick’), D. variabilis (‘American dog tick’), Amblyomma americanum (‘Lone Star tick’), A. maculatum (Gulf Coast tick), Ixodes scapularis (formerly I. dammini, ‘Blacklegged tick’) and I. pacificus (‘Western Black-legged tick’). Peak incidence occurs between April and June when nymphs and mature adults abound in low vegetation and climb upward, questing for their next host by extending their anterior pairs of legs.[1,3,4] Paralysis is a response to a neurotoxin secreted by the salivary glands of the arachnid.[1,5] The biochemistry and pharmacology of the specific paralysis- inducing toxins produced in North American ticks are yet to be fully elucidated, but current evidence points to a mechanism by which the toxins inhibit presynaptic acetylcholine release at the neuromuscular junction.[1,3,6] TP presents more often and more severely in children, suggesting a concentration-dependent relationship between toxin levels and symptom expression.[1,4] Signs and symptoms of TP begin about five to six days after the parasite has attached, when neurotoxin is secreted at its peak levels. These prodromal symptoms include restlessness, irritability, fatigue, nausea, paresthesias and possibly ataxia. Over the next 24-48 hours, the patient develops ascending symmetrical flaccid paralysis and weakness in the lower extremities. Over the course of the next day or two, paralysis and weakness may ascend to involve the trunk, axial and upper limb muscles. Cranial nerves may also become involved in an ascending pattern, resulting in bulbar, facial and/or extraocular paralysis. Patients demonstrate diminished or absent deep tendon and superficial reflexes while, aside from occasional paresthesias, their sensory exam remains normal. Pain and fever are absent. Death ensues following paralysis of the respiratory muscles.[1,5,7,8,9] Atypical presentations reflect variations in the site of tick attachment. There may be ataxia and associated cerebellar deficits without accompanying muscle weakness. The disorder may also present as an isolated facial paralysis without trunk or limb involvement. Another group of atypical presentations is unilateral paralysis and/or weakness, including isolated unilateral facial paralysis.[1,8] Tick paralysis is treated by removal of the tick. Although the site of attachment is most often the head and neck region, the entire body should be scrutinized, including ear canals, nostrils and genitalia. Multiple ticks should be suspected, and all must be removed.[1,4,7,10] Applications of petroleum jelly, nail polish, alcohol, a needle and heat are inappropriate. These measures may result in infection and cause the parasite to salivate or regurgitate more of its bodily fluids.
The tick should be grasped with blunt, angled forceps as close as possible to the skin and to the embedded mouthparts (hypostome). Wearing protective gloves, slowly pull the organism straight outward with a gentle and steady traction, without twisting its body. Do not burst the tick. The hypostome is usually deeply and firmly embedded and should be removed surgically should it come detached. Antiseptic solution is then applied to the wound, and the recovered tick and severed mouthparts may be preserved in 75% ethanol for identification. The patient should be instructed to return in the event of additional illness and educated on protective measures against ticks.
The symptoms of TP, at least those caused by North American species, typically resolve rapidly following removal of all ticks from the patient. Improvement in the condition of the patient subsequent to tick removal is confirmatory for the diagnosis. Species found in some other parts of the world, notably Ixodes holocyclus of Australia, produce a very potent neurotoxin and symptoms may not subside as quickly, even worsening after removal.[5] The prognosis depends on clinical presentation prior to removal. If all ticks were removed prior to the onset of bulbar weakness, the patient often makes a full recovery within the first 24 hours. However, if onset of bulbar symptoms occurs during continued feeding, the likelihood of fatal respiratory paralysis increases to 10%. Therefore, prompt of diagnosis and tick removal are paramount.[1,5,7,8] Because ticks are both vectors and reservoirs for various infectious diseases, it is important to educate the patient about this added risk for possible concurrent illnesses. Table 1 displays the geographical location and infectious diseases associated with North American tick species which are also known to cause TP.[1,8,11,12]

References
1.Cunha BA, editor. Tickborne Infectious Diseases Diagnosis and Management. New York: M. Dekker; 2000.
2.Meier J, White J. Handbook of Clinical Toxicology of Animal Venoms and Poisons. STATE: CRC Press; 1995.
3.CDC. Tick paralysis – Washington. Morbidity and Mortality Weekly Report 1996; 45(16): 325-6.
4.Schmitt N, Bowmer EJ, Gregson JD. Tick paralysis in British Columbia. Can Med Assoc J 1969 Mar 1; 100(9): 417-21.
5.Meriggioli MN, Howard JF, Howard Jr. JF, Harper CM, Harper Jr. CM. Neuromuscular Junction Disorders: Diagnosis and Treatment. STATE: Informa Health Care; 2003.
6.Grattan-Smith PJ, Morris JG, Johnston HM, Yiannikas C, Malik R, Russel R, Ouvrier RA. Clinical and neurophysiological features of tick paralysis. Brain 1997 Nov;120(Pt 11):1975-87.
7.CDC. Tick paralysis – Colorado. Morbidity and Mortality Weekly Report 2006 Sep 1; 55(34): 933-5.
8.Knoop KJ, Stack LB, Storrow AB. Atlas of Emergency Medicine. STATE: McGraw-Hill Professional; 2002.
9.Biller J. Practical Neurology. STATE: Lippincott Williams and Wilkins; 2002.
10.Gammons M, Salam G. Tick removal. Am Fam Physician 2002 Aug 15; 66(4): 646.
11.Winn WC, Kineman EW, Allen SD, Janda WM, Schreckenberger PC,Procop GW, Woods GL. Koneman´s Color Atlas and Textbook of Diagnostic Microbiology. STATE: Lippincott Williams and Wilkins; 2005.
12.Sonenshine DE, Mather TN. Ecological Dynamics of Tick-borne Zoonoses. STATE: Oxford University Press US; 1994.
13.Greenberg BM. Clinical cases in neurology from John Hopkins. Case 2: acute ascending paralysis in a 4-year-old body. MedGenMed 2003 Apr 9; 5(2): 36.

Dr. Gordon’s Comments:

Lead poisoning again is on the front page of The New York Times yet no one understands this fact – there is no safe level in children. So why would anyone allow any woman to go through pregnancy without at least some of my detox program – power drink or oral chelation like Beyond Chelation-Improved or Zeolite? Why not all three, as no one approach can deal with all the toxins we find in every newborn today and it all comes FROM THE MOM.

Please understand we all have too much lead and during pregnancy the body transfers the mothers lead and other toxins to the baby and also concentrates it six fold. How can we continue to ignore this epidemic when we have safe affordable answers? Maybe you can get at least 8 gm. of BIOEN’RGY C into a pregnant women daily, as that too is an oral chelator. But let’s do something about the TEN AMERICANS report by www.ewg.com that proves every child born is loaded with carcinogens neurotoxins and endocrine disruptors.

The parents to be save $3000 or so by not going on appropriate nutritional products for detox during the entire pregnancy, but best results will be when starting 1 year before the pregnancy and treat the dad too! Or pay $250,000- 500,000 in extraordinary health care costs to deal with what could have been prevented with a little rational family planning.

“No blood lead level has been found to be safe for a child,” Dr. Mary Jean Brown, chief of the lead poisoning prevention branch of the Centers for Disease Control and Prevention, said in an interview last week.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://www.nytimes.com/2011/06/15/world/asia/15lead.html

Excerpt:

June 15, 2011
Lead Poisoning in China: The Hidden Scourge
By SHARON LaFRANIERE

MENGXI VILLAGE, China — On a chilly evening early last month, a mob of more than 200 people gathered in this tiny eastern China village at the entrance to the Zhejiang Haijiu Battery Factory, a maker of lead-acid batteries for motorcycles and electric bikes. They shouldered through an outer brick wall, swept into the factory office and, in an outpouring of pure fury, smashed the cabinets, desks and computers inside.

Dr. Gordon’s Comments:

Light for Alzheimer’s?  Anything that improves circulation is now seen as having benefits for Alzheimer’s disease, why not PEMF too?

We have no shortage of suggestions that can do that including IV and Oral Chelation but now we find we can also benefit from including all forms of  Oxygen, not just HBO,  hyperthermia, even FIR saunas, all forms of  light, including  low level lasers,  and many forms of electricity  like the new one  approved for brain cancer. We also have seen great success with microcurrent devices and also with high voltage low amperage Tesla based electric muscle stimulation, as available from Renua Medical. 

Watch my three webinars on my website about PEMF or go to YouTube and see stories about dramatic successes with PEMF in Autism, Parkinson’s disease even Guillian Barre at www.pemf.us/info. Whatever you do should include effective PMT-100, as part of your treatment as PEMF is turning on stem cells too! Otherwise it could not heal old non-union fractures, as it is proven to do! So now it is treating depression  but it takes 6 weeks, which I believe is because that is the needed lead time to get meaningful stem cell production!  It took that long to give me a new back and better kidneys.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://www.qmed.com/mpmn/blog/41699/could-light-based-alzheimers-devices-be-next-big-thing

Excerpt:

Could Light-Based Alzheimer’s Devices Be ‘The Next Big Thing’? 
Published: March 23, 2011

Not only is Alzheimer’s disease (AD) the sixth leading cause of death in the United States, it is also the only one in the top 10 that can’t be prevented, cured, or slowed, according to the Alzheimer’s Association. Although treatments for the brain disease traditionally have been drug-based in the form of cholinesterase inhibitors and memantine, recent research indicates that AD symptoms may be alleviated through the use of light-based treatments. If further studies support these claims, could light-based AD treatments soon emerge as a lucrative new medical device market segment? Will light-based AD treatments be the ‘next big thing?’

This is vital information; most bypass and stents are operating on the wrong lesions.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://www.medscape.com/viewarticle/724138

Excerpt:

From Heartwire 
Building Multimodality Pictures to Unlock the Secrets of Vulnerable Plaques
Reed Miller

June 24, 2010 (Hamburg, Germany) — Researchers are developing techniques combining intravascular ultrasound (IVUS) “virtual histology” (VH) with positron-emission tomography (PET) and computed tomography (CT) that they hope will someday predict which coronary plaques trigger MIs.

Dr Martin Bennett (Cambridge University, UK) discussed his group’s research into vulnerable plaque imaging here at the European Atherosclerosis Society (EAS) EAS 2010 Congress. “We know what a vulnerable plaque is–[it is characterized by] a loss of smooth-muscle cells, inflammation, platelet aggregation, expansion of lipid cores. But if we’re trying to detect these features with imaging, we need to focus on particular structural or functional components of those plaques that we can detect using noninvasive imaging techniques.”

IVUS VH, a technology developed by Volcano (San Diego, CA), analyzes ultrasound “backscatter” patterns to differentiate plaque constituents in IVUS coronary images. IVUS VH’s ability to identify fibrous tissue, fibrous fatty tissue, necrotic core, and dense calcification has been validated in postmortem studies with sensitivity and specificity up to 95% to 98%. By assigning different colors to different constituent materials in the vessel wall, IVUS VH can show the thin-cap fibrous atheromas, also known as vulnerable plaques.

Bennett and colleagues studied 200 patients with IVUS VH to see how the coronary substrate wall was different between patients with stable angina and unstable-angina patients. So far, the researchers have processed over 200 m worth of plaque, or about 750 plaques.

This is very interesting research that would cause you to want to take exposure to flu more seriously!  First, let’s stay healthy so we do not get flu or colds with all that I discuss from Immuni-T 2 and 3 to long term detoxification, as in FIGHT program. Then since for many that is too rigorous a requirement, so let’s have an EMERGENCY SUPPORT PACKAGE in the homes of anyone that realizes who important this new research is!  Have BioE’nR-G’y C, ACS 200, and high dose D AND A available to immediately begin at the first sign of active infections.

What if their vaccines turn out to be as wrong for stopping H1N1, as MMR has been shown to be for compromised children? After MMR in autistic kids the live virus from the vaccination later has been shown to be growing in the CSF of these children.  Will the current testing of the new swine flu vaccines even attempt to look for how many receiving the vaccines actually wind up being infected with the virus instead of being protected against the virus, as they are not able to launch an immune response to the vaccine?

It appears that the virus accesses the neuron through the axons in the GI tract and lung. This sets the stage then for loss of Dopamine secreting cells over time.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Recent studies have suggested that the currently circulating strain of avian influenza has similar pathology to the 1918 flu. Though the subtypes of the viruses are different (Spanish flu shares the H1N1 subtype with the current H1N1 swine flu, whereas avian influenza has an H5N1 subtype), both viruses appear to enter the central nervous system (CNS) and can cause encephalitis, or inflammation of the brain.

Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
http://www.pnas.org/content/early/2009/08/07/0900096106.abstract

1.       Haeman Janga,b,
2.       David Boltzc,
3.       Katharine Sturm-Ramirezc,1,
4.       Kennie R. Shepherda,2,
5.       Yun Jiaoa,
6.       Robert Websterc and
7.       Richard J. Smeynea,3

+Author Affiliations
1.       Departments of aDevelopmental Neurobiology and
2.       cInfectious Diseases/Virology, St. Jude Children’s Research Hospital,
262 Danny Thomas Place, Memphis, TN 38105-3678; and
3.       bIntegrated Program in Biomedical Sciences, University of Tennessee
Health Science Center, Memphis, TN 38163
1.      1Present address: Fogarty International Center, National Institutes
of   Health, 16 Center Drive, Room 202, Bethesda, MD 20892.
2.      2Present address: Department of Environmental and Occupational
Health, Rollins School of Public Health and Center for
neurodegenerative Disease, Emory University, Whitehead Biomedical
Research Building, 5th Floor, Room 575.1, Atlanta, GA, 30322.

Abstract
One of the greatest influenza pandemic threats at this time is posed by the highly pathogenic H5N1 avian influenza viruses. To date, 61% of the 433 known human cases of H5N1 infection have proved fatal. Animals infected by H5N1 viruses have demonstrated acute neurological signs ranging from mild encephalitis to motor disturbances to coma. However, no studies have examined the longer-term neurologic consequences of H5N1 infection among surviving hosts. Using the C57BL/6J mouse, a mouse strain that can be infected by the A/Vietnam/1203/04 H5N1 virus without adaptation, we show that this virus travels from the peripheral nervous system into the CNS to higher levels of the neuroaxis. In regions infected by H5N1 virus, we observe activation of microglia and alpha-synuclein phosphorylation and aggregation that persists long after resolution of the infection. We also observe a significant loss of dopaminergic neurons in the substantia nigra pars compacta 60 days after infection. Our results suggest that a pandemic H5N1 pathogen, or other neurotropic influenza virus, could initiate CNS dis

Why is FDA so afraid to alert consumers to the possibility that amalgams contribute to total body mercury levels and that combined with eating fish, which they refuse to require adequate labeling there also, means that consumers have no knowledge why they have so many health issues in their family.

It seems that the experts will disagree, as to how much mercury in our body is from coal burning for power plants that settles in oceans and comes up in the food chain vs. how much is in the particulates we breath, which in one study in San Francisco was shown to be over 30% of all the total body burden of mercury. Breathing particulates carrying mercury is the major contributor or merely the second largest contributor may vary from research paper to research paper and be somewhat related to environmental circumstances of the patient group being studied.

We are very confident, however, that there is no safe level for lead or mercury and that there are serious synergies in their toxic effects on our health. It will come to pass someday that patients will know how much is in vaccines, amalgams, fish, and air they breathe and or water they bath in and in all of the many contributors to our body burdens of lead and mercury, which becomes complex as when we are born we are already loaded with them so there is no easy way out.

So I believe the day will come that everyone will consume oral chelators or improved Zeolite products daily and they will be as available as salt and pepper wherever we eat.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

FDA’s Mercury Ruling Defies ALL Scientific Reasoning
by Dr. Mercola
August 22 2009
http://articles.mercola.com/sites/articles/archive/2009/08/22/FDA-has-the-Audacity-to-Claim-Mercury-is-Completely-Harmless.aspx

In the video above I speak with Charles Brown, legal counsel for the Consumers for Dental Choice, which is a nonprofit corporation whose purpose is to educate the public about the health and environmental dangers of mercury fillings, and to ensure more effective government oversight on amalgam. Charles discusses the processes he’s been undertaking for the last 10 years to get dangerous mercury fillings removed from the market, and brings you up to speed on where we are today with the FDA’s most recent, atrocious ruling.
The U.S. FDA has issued a final regulation classifying dental amalgam without calling for stringent precautions for pregnant women and children — even though last June a court settlement filed by the Consumers for Dental Choice required the FDA to withdraw claims of mercury amalgam’s safety from its Web site and issue an advisory indicating:
“Dental amalgams contain mercury, which may have neurotoxic effects on the nervous systems of developing children and fetuses.”
Instead, the FDA has classified the fillings as class II devices, meaning the agency is claiming that they are completely harmless. This stands in direct contradiction of the conclusions of the FDA’s own panel of scientific experts, and the findings of the International Academy of Oral Medicine and Toxicology (IAOMT).
In fact, mercury dental fillings contribute 2 to 3 times as much mercury to the human body as all dietary and environmental sources combined. IAOMT is urging the FDA to change the ruling, ban dental amalgam from commerce and issue a mandatory recall on the product.

Charles Brown says:
“FDA broke its contract and broke its word that it would put warnings for children and unborn children for neurological damage. Bowing to the dental products industry, FDA for the first time in its history pulled a warning about neurological harm to children.”
“This contemptuous attitude toward children and the unborn will not go unanswered,” said Brown.  “We will see FDA in court.”
Vapors from dental mercury go into the human body. Due to mercury waste, amalgam is also increasingly targeted by environmentalists. Amalgam has also become controversial because the middle-class has largely moved to non-toxic alternatives while the poor, minorities, and institutional recipients, such as soldiers and prisoners, still get mercury amalgam.

Sources:

Medical News Today July 29, 2009

International Academy of Oral Medicine & Toxicology Press Release (PDF)

International Academy of Oral Medicine & Toxicology Position Paper on Dental Amalgam (PDF)

In the past, I have sent you emails about HEPARIN and I mentioned consulting with ww.thrombocare.com in Texas. I am sorry to report that their director Rodger Bick MD PhD, hematologist, Pathologist from University of Texas is deceased and their lab is closed. I believe that he was one of the leading authorities in the world about coagulation related issues, and that, as he said, 2 million die each year from blood clots that are usually called MI’s strokes or pulmonary emboli, so we need to provide a better answer than Coumadin, Plavix etc. That is 2 million deaths that I find are largely avoidable with the right blood viscosity lowering approach!

Patients contact me daily about how Coumadin is wrecking their life. Now then, I have for years believed in the INFORMED CONSENT approach in which a fully informed patient is free to decide for themselves what treatment to follow. Once a patient has read my informed consent approach to Coumadin (see www.gordonresearch.com  and use search and type in Coumadin and do the same SEARCH on FACT to learn more and find my Informed Consent).

Then I believe that  anyone is  entitled to accept full personal responsibility for not using mainstream drugs for their clot prevention, or to augment the effect of their standard meds with alternatives like BC-I, with or without Boluoke. That is my standard MINIMUM alternative approach. However, we have patients with serious histories of obvious coagulopathies and they deserve the best lab tests to try to understand the predicament in which they find themselves. Big Labs like Quest and LAB Core charge $1200 for their panels but there is always more to learn about how to interpret the tests and which tests to use.

I inform all my patients that there is no established test to provide the assurance that they are adequately lowering platelet adhesiveness or getting enough anticoagulant benefit. There is one patient that has gone to the extreme and is using Essential Daily Defense, Boluoke, Endokinase, BC-I and extra OMEGA 3, all in large quantities but is able to keep his INR in the ranges he was accustomed to on Coumadin, which he could not tolerate.

Clearly there is still a great deal to learn about all of this and I have just discussed this with DAVID BERG formerly lab director of HEMEX labs. He has formed ARIZONA COAGULATION CONSULTANTS in PHOENIX at 602 793 4361 and his email is davidberg@azrf.org.  He charges a minimum of $50 for any consultation with health professionals and $100 per hour for more lengthy consultations.

He is not a MD but he has extensive experience in this area that I believe may be helpful when you are contacted by a patient with a history that could be a genetic linked coag defect, as in LEIDEN 5, which is found in 5% of our population or may have chronic infections that have led to ANTIPHOSPHOLIPID SYNDROME. He is not going to tell patients that my suggestions above are adequate or recommend therapy but I see that the need is to help patients QUANTIFY the extent of their RISK.

That means more patients over time will need tests and most have no idea of what is covered and which labs to use and what tests could cost them, which is information that I believe David Berg can offer assistance with for your problem patients with histories of clot related problems. The more you learn, the more things will be seen to relate to increased blood viscosity and/or hypercoagulability.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#1
Dear Dr. Gordon:

In 2004 you helped me start to get off the drug coumadin by introducing me to the Longevity Plus EDD capsules that have EDTA in them and garlic. We found that three EDD caps every four hours during my waking hours would duplicate coumadin. My INR was almost 2.0 without any coumadin which has major negative side effects. I have a one inch St. Jude mechanical aortic heart valve.

For years I also took nattokinase. You recently introduced me to Boluoke which lasts longer and works better.

I had to quit one of the finest jobs I ever had due to temporary strokes during the day. I went to leading top neurologists and they said the problem was blood clots caused by my mechanical aortic heart valve. They had no solution but you did: EDD capsules and nattokinase. (Now Boluoke.)

Here is my current daily EDD and Boluoke schedule:

7:00 AM One capsule Boluoke, three EDD capsules, and one 1000mg. Carlson fish oil capsule.
11:00 AM One fish oil cap and three EDD caps.
3:30 PM One fish oil caps and three EDD caps.
6:30 PM One fish oil cap and three EDD caps.
7:00 One Boluoke cap. (Evening dosage.)
10:00PM Just before bedtime, to cover me all night, I take three EDD caps and one fish oil cap.

God Bless and keep you safe,
JT
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

#2
Dear Dr. Gordon,

Eight years ago, I had my first heart attack. I was stented emergently in my LAD coronary artery, and later stented electively in my right coronary artery.

After recovery, I did all the recommended things like taking the cardiac rehab course offered by the hospital, taking my post op drugs like blood thinners, ACE inhibitors, beta-blockers, and a statin. Then I found your web site and your publications.

Soon, I was off all drugs, getting all my necessary metabolic needs via diet, and supplements, and your package, Beyond Chelation Improved. I was doing all the right things, promoting your BCI, and feeling very good. This got me eight years of life with absolutely no symptoms. Two weeks ago, I had a second heart attack.

I had a feeling when I was again transported to the hospital that the problem wasn’t diffuse disease but a narrowing stent lumen which indeed was exactly the case. All distal arteries were open and clear of any detectable disease but the old stent had fibrosed to 99% occlusion. The fibrotic section was cleaned out and a new stent was placed inside the old stent. (If your work would be enhanced by images of the before and after arteriogram please let me know and I will forward you images of the scans.)

Bottom line, I feel great and judging from the arteriogram, it appears that the supplement program and the BCI did as advertised and kept my heart arteries clean and clear, without the side effects of all the big-pharma recommended drugs with all their attendant side effects. I did agree to take Plavix for a while, (the cardiologist said for at least a year, however, I think I will ease off this and substitute nattokinase).

Anyway, here is my present question: is there something I could have done and could now do that would have prevented the stent from the fibrosis? It seems to me that there should be some natural substance that might have minimized the risk of fibrosis or from the foreign body reaction that occurred in my stent. FYI, my original stent was not the “medicated” type since at the time, there was no medicated stent on-hand large enough for my coronary artery (5mm).

I am convinced that the BCI works but for those like myself who have stents, is there another therapy that I can use to prevent a recurrence? FYI, I am not your average ‘civilian’ heart patient. For eight years, I was a cardiopulmonary perfusionist, the person that operates the heart lung machine during heart surgery.

Thanks in advance,
MS
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Dear MS:
Thanks for sharing your important information! I am sorry that you had the second heart attack. I expect, however, that you can regain high functioning although for awhile you may want to consider use of CO-Q, Carnitine, Ribose, Testosterone, and other things I write about continually to the 2000 health professional members of FACT.

I think it is really important for us to let others hear of your story. Everyone with a stent then ideally needs to be on Beyond Chelation-Improved AND either Nattokinase or Boluoke. I believe you are right; you definitely have great alternatives to Plavix that offer better protection with less side effect. I would replace it or Coumadin with Nattokinase (Endokinase) or Boluoke taken twice a day.

As you read up on both, you will see that they have slightly different mechanisms of action and it appears that Boluoke is a bit stronger. Since Boluoke is also more expensive I have some patients use one of each (ie take the Nattokinase each AM and the Boluoke each PM).

The question is to save money would short term use of the enzyme as for several months be sufficient?  I am afraid to gamble. You could use more aggressive doses for a couple of months in an effort to reduce some blockages but I feel that we all have excessive clotting tendencies for many reasons today, and I would recommend LIFE TIME protection with one of those enzymes for you. I believe today with the toxins and pathogens we find in all of us, that my future recommendations are going to HAVE to include Boluoke or Nattokinase for everyone with a history of a heart attack and certainly for anyone that has a stent.

BC-I clearly continues to keep people alive around the world all by itself so it continues to prove its usefulness, but with the increasing pollution, and the presence of a foreign material like a stent, in a patient with a history of a prior heart attack, it is clear that adding one of those enzymes is necessary for optimal protection.
Sincerely,

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Lyme seems suddenly to be everywhere and now we learn that most of us have Cytomegalic Virus too. This new research helps explain the sudden increase in Lyme world wide!

This information combined with the CMV research should be enough that, when considered altogether, leads me to believe that soon infections might overtake all other challenges including toxins, heavy metals, food sensitivities etcetera, as the key missing culprit that must be dealt with in all chronic disease patients if you are to see real lasting results!

INFECTION CONTROL- with ACS 200

ACS 200 becomes increasingly important since not too many will follow for any length of time the other suggestions for controlling chronic infections that I have made such as higher doses of BIOE’NR-G’Y C, which virtually anyone can handle in 8 gm a day or higher levels. Use C Stix to involve patients in the benefits of Vitamin C rich urine, as proof of ongoing detoxification effects. Also recommended are Immuni-T 2 or Vit D or Kyolic or short term use of high dose Vitamin A.

Most U.S. based patients have difficulty locating doctors offering IV UVB and Ozone. That is sad since it provides a great way to start any treatment to lower total body burden of all Pathogens. As an alternative, patients can use ACS very aggressively for a time. Start with 1 ounce and then use 1-2 ounces a day of ACS 200, as a part of their infection control program until results are being seen, usually 2-4 weeks minimum. Then lower the ACS dose to save money, BUT DO NOT STOP TAKING ACS 200, using at least doses of 30 sprays tid-qid for several months or even years along with my other suggestions.

Then follow my FIGHT program so that their own body over time can help control their total body burden of these newly recognized pathogens that clearly none of us can avoid. Read Plague Times by Ewald and get the full story on infections!

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Discovery Of Lyme Disease Bug Clone May Explain Disease Spread
ScienceDaily (June 29, 2008)
http://www.sciencedaily.com/releases/2008/06/080626145806.htm

Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and colleagues discovered that a certain clone of Borrelia burgdorferi, the spirochete that causes Lyme disease, appears to be the most common strain causing Lyme disease in North America and Europe, and may account for the increase in cases for the past 20 years.
According to Dr. Luft, Lyme disease is the most common vector-borne disease in the United States with more than 20,000 cases reported annually. While B. burgdorferi is the primary pathogen in the United States, clones of the pathogen are known to cause major disease. The ospC-A clone was one of the first strains ever identified.
In a new article, Dr. Luft and colleagues detail various methods of genetic testing of 68 B. burgdorferi isolates from Europe and North America. Based on the findings of their tests, the researchers concluded that the ospC-A clone dispersed rapidly and widely in the recent past and in both regions of the world.
“I believe this discovery will make an important contribution since it identifies an identical and high virulence clone of Borrelia in both Europe and North America,” said Dr. Luft. “This may explain the recent spread of Lyme disease in North America.”
The researchers report that the isolates of the clone were prevalent on both continents and uniform in DNA sequences, which suggests a recent trans-oceanic migration. More specifically, they explained: “The European and North American Populations of B. burgdorferi sensu stricto have diverged significantly because of genetic drift. Plasmid genes evolved independently and showed various effects of adaptive divergence and diversifying selection…genetic variation within the two continents contributed to most of the total sequence diversity, which suggests recent common ancestry, migration, or both, between the European and North American populations.”
The research was funded partly by the Lyme Disease Association and the National Institutes of Health. Dr. Luft’s colleagues include: Wei-Gang Qui, Ph.D., and William D. McCaig, Hunter College of the City University of New York; John F. Bruno and Yun Xu of Stony Brook University; Ian Livey, Baxter Vaccine AG, Orth/Donau, Austria, and Martin M. Schriefer, of the Centers of Disease Control and Prevention, Fort Collins, Colorado.
________________________________________
Journal reference:
1. . Wide Distribution of a High-Virulence Borrelia burgdorferi Clone in Europe and North America. Emerging Infectious Diseases, July 2008
Adapted from materials provided by Stony Brook University Medical Center.

What should you focus on to help the most patients? Putting good things in, or getting bad things out, or killing some of the infections we all have? The answer is beginning to be clear; it is NOT EITHER/ OR but EVERYTHING!

The front cover of Time June 6 2008 has a picture of a baby and the key article is The Truth About Vaccines. For once it admits there is a problem and that many are going to opt out of vaccinating their children. There are other useful comments in their article but I draw your attention to their conclusion that GENETICS and ENVIROMENTAL exposures must be behind the increase in AUTISM.

That is a major point for meaningful discussion when you learn about toxins causing epigenetic changes in genes almost overnight that affect all offspring from Duke University and Randy Jirtle’s work. You can begin to piece together a more effective and broadly based treatment plan that will help many more patients with the complex degenerative and neurological conditions.

Methylation support begins to be as critical as detoxification, chelation and lowering pathogens. Looking at the potential exposures in the maternal diet, like BISPHENYL A that lead to all the mice offspring having yellow not brown fur and all developing obesity and diabetes, means that we have to go back to looking at the parents and their diet to tease out some of these epigenetic changes that set the stage for the inability to deal with things like Mercury in air from coal burning, or the mercury coming from the mothers diet and teeth, or the mothers intake of other challenging substances, which are too numerous to count.

But we should always expect that all of us are blind men examining an elephant and some of us are sure it is a wall while other are sure it is a rope or some think it is a tree; bottom line it is all MULTIFACTORIAL. With that said, then anything we do should help, as all of what we believe in is relevant. Yes, get off the reactive foods, and with the new information out about GM food, rely only on organic food. Yes, everyone will be better the lower we get their levels of heavy metals with chelation or their other toxins with a combination of things that I call my Power Drink (BioEn’R-G’y C, MACA, Green Powder, and Beyond Fiber), which can be amplified with various other herbs and homeopathics and sweating in Saunas and soaking in EDTA bath (Beyond Clean).

But, since everyone today has a serious PATHOGEN LEVEL in their body that are poorly responsive to standard antibiotics, antiviral and antifungal, the benefits all too often seem to be short lived. So the infectious disease specialists simply go stronger, go to parenteral administration, and take the therapy longer and longer.

There are a few of us who understand the importance of advanced Methylation support. Some will rely primarily on B12 using injections, which with Beyond B12 are really no longer needed when you use it with BioEn’R-G’y C for added methylation support. This is partly because Beyond B12 (and H.R. T. Plus) has the ACTIVE form of natural Folic Acid, 5’MTHF. This form is vital for a full functioning methylation cycle that is critical to so many vital functions in the body particularly for older or sick patients.

It seems that whatever we look for, we will find. If we send blood to Mt Sinai School Of Medicine ALL will have Neurotoxins and Carcinogens in their blood stream at all times.

If we look hard with the best tests for CMV, Mycoplasma, Chlamydia we will find some or all of these and multiple other pathogens and even parasites, when we look enough.

When we look for genetic disturbances that contribute to the patient’s health issues, they will be there.

If we look for nutritional deficiencies, they are always present particularly with functional tests or intracellular analysis of things like Magnesium and there are always amino acid and fatty acid and mineral deficiencies present.

So this is like those who specialize in antique car restoring, there is work to be done wherever we look.

The good news is that some of those fully restored cars have value above what it cost to restore them and the same is true about the patients that you restore, when you provide full tail light to bumper restorative care to almost any patient with chronic degenerative condition no matter what it is called. Even if it is thought to be all a genetic problem, they too will have all of the above issues that are always present if tested for. Yet we are afraid to help such patients and abandon them to some “expert” on rare genetic diseases that has never given anyone orthomolecular levels of nutrients nor lowered anyone’s levels of toxins or pathogens!!

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Antibiotics that treat Lyme disease may help some people with autism.

This article was written to describe the possibility that autism is made worse by Lyme disease. Many doctors and parents have noticed that mothers who had Lyme disease were more likely to give birth to children with autism. Also many adults who get Lyme disease have symptoms that are like autism. The authors believe that 20-30% of autism may be caused by the bacteria that cause Lyme disease. They believe that another infectious agent (Mycoplasma) may be a factor in 58% of cases of autism.

Scientific Abstract
http://autism.healingthresholds.com/research/the-association-between-tick-bor

Med Hypotheses. 2008;70(5):967-74. Epub 2007 Nov 5

The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders.
Bransfield RC, Wulfman JS, Harvey WT, Usman AI.
Department of Psychiatry, Riverview Medical Center, 225 State Route 35, Red Bank, NJ, United States. bransfield@comcast.net
Chronic infectious diseases, including tick-borne infections such as Borrelia burgdorferi may have direct effects, promote other infections and create a weakened, sensitized and immunologically vulnerable state during fetal development and infancy leading to increased vulnerability for developing autism spectrum disorders. A dysfunctional synergism with other predisposing and contributing factors may contribute to autism spectrum disorders by provoking innate and adaptive immune reactions to cause and perpetuate effects in susceptible individuals that result in inflammation, molecular mimicry, kynurenine pathway changes, increased quinolinic acid and decreased serotonin, oxidative stress, mitochondrial dysfunction and excitotoxicity that impair the development of the amygdala and other neural structures and neural networks resulting in a partial Klüver-Bucy Syndrome and other deficits resulting in autism spectrum disorders and/or exacerbating autism spectrum disorders from other causes throughout life. Support for this hypothesis includes multiple cases of mothers with Lyme disease and children with autism spectrum disorders; fetal neurological abnormalities associated with tick-borne diseases; similarities between tick-borne diseases and autism spectrum disorder regarding symptoms, pathophysiology, immune reactivity, temporal lobe pathology, and brain imaging data; positive reactivity in several studies with autistic spectrum disorder patients for Borrelia burgdorferi (22%, 26% and 20-30%) and 58% for mycoplasma; similar geographic distribution and improvement in autistic symptoms from antibiotic treatment. It is imperative to research these and all possible causes of autism spectrum disorders in order to prevent every preventable case and treat every treatable case until this disease has been eliminated from humanity.
PMID: 17980971 [PubMed – in process]